1.Majio outcomes in high-risk hypertensive patients ran-domized to angiotesin-converting enzyme inhibitor or calciumchannel blocker vs diuretic.The antihypertensive and lipid-lowering treatment to prevent heart attack trial(ALLHAT)[].The Journal of The American Medical Association.2002 被引量：1
2Goldmann A,Herzog T,Schaffer J,et al.Prevalence of neurovascular compressionin patients with essen-tial and secondary hypertension[].Clinical Nephrology.2007 被引量：1
3Neutel J M,Smith DHG,Weber MA,et al.Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension:the Sys-tolic Evaluation of Lotrel Efficacy and Comparative Therapies(SELECT)study[].Clin Hypertens(Green-wich).2005 被引量：1
4Franklin SS,Jacobs MJ,Wong ND,et al.Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Analysis based on National Health and Nutrition Examination Survey (NHANES) III[].Journal of Hypertension.2001 被引量：1
5Lewington S,Clarke R,Qizilbash N,et al.Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies[].The Lancet.2002 被引量：1
6Kannel WB.Elevated systolic blood pressure as a cardiovascular risk factor[].The American Journal of Cardiology.2000 被引量：1
7Black HR,Elliott WJ,Grandits G,et al.Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial[].Journal of the American Medical Association The.2003 被引量：1
8Mancia G,de Backer G,Dominiczak A,et al.2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)[].Journal of Hypertension.2007 被引量：1
9Appel L J,Moore T J,Obarzanek E,et al.A clinical trial of the effects of dietary patterns on blood pressure[].The New England Journal of Medicine.1997 被引量：1
10Beckett NS,Peters R,Fletcher AE,et al.Treatment ofhypertension in patients 80 years of age or older[].The New England Journal of Medicine.2008 被引量：1
9CoRi R,Fayad ZA,Fuster V,et al.Effects of lipid lowering by simvastatin on human atherosclerotic lesions[J].Circulation,2001,104(3):249-252. 被引量：1
10Borgh C,Dormi A,Venmesi M,et al.Use of lipid lowering drug and blood pressure control in patients with arterial hypertension[J].Clin Hypertens,2002.15(6):411-419. 被引量：1
